What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News Agenus–Zydus $141m immuno-oncology deal sets stage for global BOT/BAL expansion and U.S. biologics manufacturing pivot Agenus partners with Zydus in a $141M deal to expand BOT/BAL globally and transfer U.S. biologics assets—find out what it means for cancer immunotherapy. byPallavi MadhirajuJune 4, 2025